Bob Stevens, My Experience with MPS II
Bob Stevens is not only the CEO of the MPS Society UK but has two boys who live with MPS II. In this heartfelt video, he discusses the impact of a diagnosis on the family, and the importance of relationships between all members of the care team.
The mucopolysaccharidosis (MPS) diseases are a group of rare, genetic, metabolic disorders. All MPS diseases are inherited in a recessive pattern, meaning that some people might be carriers of the disease but are unaffected. MPS II is different from the other MPS diseases because its inheritance is X-linked, meaning that males are almost exclusively affected.1
People with MPS do not have enough, or any, of an enzyme that is needed to break down a sugar, called a mucopolysaccharide or glycosaminoglycan (GAG). As a result, GAGs build up throughout the body and can cause damage to cells.1
There are seven types of MPS disease that each lack different enzymes required to break down GAGs. All of the MPS disorders are progressive, meaning they worsen with time. They are also all heterogeneous, meaning that they can affect different people differently, often resulting in a spectrum of clinical severity from mildly to severely affected.1
For more information on Hunter syndrome (MPS II), please visit http://www.huntersyndrome.info/
The information found on this channel is not exhaustive, and is not intended to diagnose or advise in the treatment of any illness or disease. This information should not be used in place of advice from your general practitioner or other healthcare professional. If in doubt, please contact your doctor for advice.
Takeda Pharmaceutical Company Limited. All rights reserved.
C-ANPROM/INT//5629
June 2019
References:
1. Scarpa M et al. Mucopolysaccharidosis type II: European recommendations for the diagnosis and multidisciplinary management of a rare disease. Orphanet J Rare Dis 2011; 6: 72.
Видео Bob Stevens, My Experience with MPS II канала Hunter Syndrome
The mucopolysaccharidosis (MPS) diseases are a group of rare, genetic, metabolic disorders. All MPS diseases are inherited in a recessive pattern, meaning that some people might be carriers of the disease but are unaffected. MPS II is different from the other MPS diseases because its inheritance is X-linked, meaning that males are almost exclusively affected.1
People with MPS do not have enough, or any, of an enzyme that is needed to break down a sugar, called a mucopolysaccharide or glycosaminoglycan (GAG). As a result, GAGs build up throughout the body and can cause damage to cells.1
There are seven types of MPS disease that each lack different enzymes required to break down GAGs. All of the MPS disorders are progressive, meaning they worsen with time. They are also all heterogeneous, meaning that they can affect different people differently, often resulting in a spectrum of clinical severity from mildly to severely affected.1
For more information on Hunter syndrome (MPS II), please visit http://www.huntersyndrome.info/
The information found on this channel is not exhaustive, and is not intended to diagnose or advise in the treatment of any illness or disease. This information should not be used in place of advice from your general practitioner or other healthcare professional. If in doubt, please contact your doctor for advice.
Takeda Pharmaceutical Company Limited. All rights reserved.
C-ANPROM/INT//5629
June 2019
References:
1. Scarpa M et al. Mucopolysaccharidosis type II: European recommendations for the diagnosis and multidisciplinary management of a rare disease. Orphanet J Rare Dis 2011; 6: 72.
Видео Bob Stevens, My Experience with MPS II канала Hunter Syndrome
Показать
Комментарии отсутствуют
Информация о видео
Другие видео канала
Differential diagnoses of MPS II, presented by Professor Umut AkyolAwareness and diagnosis of Hunter syndrome (MPS II)Surgery and otorhinolaryngology: MDT management of Hunter syndrome (MPS II)Anaesthesia: MDT management of Hunter syndrome (MPS II)My most memorable MPS II diagnosis, Anna Tylki-SzymanskaChristina Lampe, Familial ConnectionsAn Introduction to the MPS Family, presented by Professor Roberto GiuglianiMy career in MPS (mucopolysaccharidosis) – with Dr Christina LampeSigns and symptoms of Hunter syndrome (MPS II) - The Balancing Act (Part 1)Simulation of a perioperative (ENT) complication in a Hunter patient, presented by Dr Florian LaglerProfessor Maurizio Scarpa: a metabolic paediatrician’s experience with MPS IIProfessor Maurizio Scarpa: working with families affected by MPS IIElsa Shapiro Measuring Cognition in MPS IIProfessor Umut Akyol: an ENT specialist’s perspective on the diagnosis and management of MPS IIHunting Hunter syndrome: a rare disease hidden among childhood complaintsLiving with Hunter syndrome (MPS II) - The Balancing Act (Part 2)Professor Umut Akyol: an ENT specialist’s perspective on MPS IIMy career in MPS (mucopolysaccharidosis) – with Professor Roberto GiuglianiHunter Syndrome (MPS II): an uncommon combination of childhood complaintsMy career in MPS (mucopolysaccharidosis) – with Professor Maurizio Scarpa